E-LIB Suche - Ergebnisse für: Bradley K. Ackerson

1

Antibiotic Resistance of Urinary Tract Infection Recurrence..:

Ku, Jennifer H ; Tartof, Sara Y ; Contreras, Richard...
The Journal of Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

2

Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalen..:

Ackerson, Bradley K. ; Bruxvoort, Katia J. ; Qian, Lei...
Human Vaccines & Immunotherapeutics. 20 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

3

Risk factors for recurrent urinary tract infections among w..:

Ackerson, Bradley K ; Tartof, Sara Y ; Chen, Lie H...
The Journal of Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

4

Effectiveness of BNT162b2 XBB Vaccine against XBB and JN.1 ..:

Tartof, Sara Y ; Slezak, Jeff M ; Puzniak, Laura...
Open Forum Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

5

Predictors of nirmatrelvir–ritonavir receipt among COVID-19..:

Malden, Deborah E. ; McLaughlin, John M. ; Hong, Vennis...
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

6

Reactions following Pfizer-BioNTech COVID-19 mRNA vaccinati..:

Malden, Deborah E. ; Gee, Julianne ; Glenn, Sungching...
Vaccine. 41 (2023) 2 - p. 315-322 , 2023

Link: https://doi.org/10.1016/..

7

Real‐World Evidence to Supplement Randomized Clinical Trial..:

Skarbinski, Jacek ; Fischer, Heidi ; Hong, Vennis...
Clinical Pharmacology & Therapeutics. 114 (2023) 5 - p. 1073-1081 , 2023

Link: https://doi.org/10.1002/..

8

Effectiveness of nirmatrelvir–ritonavir in preventing hospi..:

Lewnard, Joseph A ; McLaughlin, John M ; Malden, Debbie...
The Lancet Infectious Diseases. 23 (2023) 7 - p. 806-815 , 2023

Link: https://doi.org/10.1016/..

9

Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine agai..:

Tartof, Sara Y ; Slezak, Jeff M ; Puzniak, Laura...
The Lancet Respiratory Medicine. 11 (2023) 12 - p. 1089-1100 , 2023

Link: https://doi.org/10.1016/..

10

BNT162b2 Against COVID-19-Associated Emergency Department a..:

Tartof, Sara Y ; Frankland, Timothy B ; Puzniak, Laura...
Journal of the Pediatric Infectious Diseases Society. 12 (2023) 3 - p. 177-179 , 2023

Link: https://doi.org/10.1093/..

11

mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine ..:

Tseng, Hung Fu ; Ackerson, Bradley K. ; Sy, Lina S....
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

12

Effectiveness of a fourth dose of mRNA-1273 against COVID-1..:

Ku, Jennifer H. ; Sy, Lina S. ; Qian, Lei...
Vaccine. 41 (2023) 29 - p. 4212-4219 , 2023

Link: https://doi.org/10.1016/..

13

Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 o..:

Tseng, Hung Fu ; Ackerson, Bradley K. ; Bruxvoort, Katia J....
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

14

Vaccine effectiveness of the mRNA-1273 3-dose primary serie..:

Ku, Jennifer H. ; Sy, Lina S. ; Qian, Lei...
Vaccine. 41 (2023) 24 - p. 3636-3646 , 2023

Link: https://doi.org/10.1016/..

15

Investigating Tetanus, Diphtheria, Acellular Pertussis Vacc..:

Florea, Ana ; Sy, Lina S. ; Ackerson, Bradley K....
Infectious Diseases and Therapy. 12 (2022) 2 - p. 411-423 , 2022

Link: https://doi.org/10.1007/..